Novartis is opening on Tuesday the country's first plant to produce flu vaccines using cell cultures. These vaccines are faster, better and cheaper to make than egg-based methods, reports CNBC's Mike Huckman.
Douglas Roberts, of ChannelCapitalResearch.com, and Dean Barber, of the Barber Financial Group, share their investment strategies and favorite sectors with CNBC.